What CymaBay Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Emster Kurt Von | Director | Mar 22 | Disposition to Issuer · D | −90,000 | — | — | 0 |
| Shah Sujal | Chief Executive Officer | Mar 22 | Disposition to Issuer · D | −96,250 | — | — | 0 |
| Shah Sujal | Chief Executive Officer | Mar 22 | Disposition to Issuer · D | −310,420 | — | — | 0 |
| Wills Robert James | Director | Mar 22 | Disposition to Issuer · D | −30,000 | — | — | 0 |
| Quinlan Paul T | General Counsel | Mar 22 | Disposition to Issuer · D | −28,438 | — | — | 0 |
| Quinlan Paul T | General Counsel | Mar 22 | Disposition to Issuer · D | −41,824 | — | — | 0 |
| Dickinson Klara | Chief Regulatory Officer | Mar 22 | Disposition to Issuer · D | −21,000 | — | — | 0 |
| Shantharam Harish | Chief Financial Officer | Mar 22 | Disposition to Issuer · D | −20,125 | — | — | 0 |
| McWherter Charles | President of R&D | Mar 22 | Disposition to Issuer · D | −31,938 | — | — | 0 |
| McWherter Charles | President of R&D | Mar 22 | Disposition to Issuer · D | −15,000 | — | — | 0 |
| Quinlan Paul T | General Counsel | Mar 13 | Exercise / conversion · M | +41,824 | $7.89 | +$330K | 70,262 |
| Shah Sujal | Chief Executive Officer | Mar 13 | Exercise / conversion · M | +1 | $2.94 | +$2.94 | 406,670 |
| Shah Sujal | Chief Executive Officer | Mar 13 | Exercise / conversion · M | +2,288 | $5.78 | +$13.2K | 406,669 |
| Shah Sujal | Chief Executive Officer | Mar 13 | Exercise / conversion · M | +22,076 | $4.05 | +$89.4K | 404,381 |
| Shah Sujal | Chief Executive Officer | Mar 13 | Exercise / conversion · M | +14,372 | $8.43 | +$121K | 382,305 |
| Shah Sujal | Chief Executive Officer | Mar 13 | Exercise / conversion · M | +3,125 | $11.69 | +$36.5K | 367,933 |
| Shah Sujal | Chief Executive Officer | Mar 13 | Exercise / conversion · M | +18,899 | $9.21 | +$174K | 364,808 |
| Shah Sujal | Chief Executive Officer | Mar 13 | Exercise / conversion · M | +52,084 | $1.72 | +$89.6K | 345,909 |
| Shah Sujal | Chief Executive Officer | Mar 13 | Exercise / conversion · M | +14,625 | $1.06 | +$15.5K | 293,825 |
| Shah Sujal | Chief Executive Officer | Mar 13 | Exercise / conversion · M | +11,649 | $10.00 | +$116K | 279,200 |
Loading...